3 risultati
FIELD OF THE INVENTION
The invention is directed to therapeutic methods for treating diseases associated with tumour necrosis factor-alpha (TNF-.alpha.) induced cell toxicity and/or complement induced cell toxicity, and improved methods for treating diseases whose therapy comprises the
TECHNICAL FIELD
The present invention relates to a method for determination of oxidative stress comprising measuring a substance whose blood concentration varies depending on oxidation-caused variation of reduced glutathione (GSH) concentration in abiological sample, and to a method for screening
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. National Stage of International Application No. PCT/JP2007/050517, filed Jan. 16, 2007, which claims the benefit of JP2006-012955, filed Jan. 20, 2006.
TECHNICAL FIELD
The present invention relates to a method for determination of